| 摘要 |
This invention relates to the treatment of autoimmune blistering disease. Specifically, the invention relates to the use of anti-IgB antibody, its fragments, derivatives, metabolites or their combination in methods and compositions for the treatment of bullous pemphigoid, pemphigus vulgaris, pemphigus foliaceous, cicatricial pemphigoid, anti-epiligrin pemphigoid, epidermolysis bullosa acquisita, herpes gestationis, dermatitis herpetiformis, bullous lupus, paraneoplastic pemphigous, or a combination or variants thereof.
|
